StockData
Allarity Therapeutics, Inc. logo

Allarity Therapeutics, Inc. (ALLR) stock

ALLRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 1/30
$0.84−0.03 (-3.91%)

Close on Nov 17, 2026Market cap $13.38MP/E –Yield –

Allarity Therapeutics operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Allarity Therapeutics's operating cash flow for the twelve months ending Jun 30, 2026 was -$13.71M. For fiscal 2025 it was -$14.82M. The highest annual figure on record is -$7.25M in fiscal 2020.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$14.82M–
FY2024Dec 31, 2024-$17.35M–
FY2023Dec 31, 2023-$12.75M–
FY2022Dec 31, 2022-$16.82M–
FY2021Dec 31, 2021-$14.89M–
FY2020Dec 31, 2020-$7.25M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$2.56M–
Q1 FY2026Mar 31, 2026-$4.49M–
Q4 FY2025Dec 31, 2025-$3.24M–
Q3 FY2025Sep 30, 2025-$3.41M–
Q2 FY2025Jun 30, 2025-$5.48M–
Q1 FY2025Mar 31, 2025-$2.69M–
Q4 FY2024Dec 31, 2024-$3.21M–
Q3 FY2024Sep 30, 2024-$5.44M–
Q2 FY2024Jun 30, 2024-$7.30M–
Q1 FY2024Mar 31, 2024-$1.40M–
Q4 FY2023Dec 31, 2023-$1.67M–
Q3 FY2023Sep 30, 2023-$5.38M–
Q4 FY2022Dec 31, 2022-$2.45M–
Q3 FY2022Sep 30, 2022-$4.41M–
Q2 FY2022Jun 30, 2022-$4.21M–
Q1 FY2022Mar 31, 2022-$5.76M–
Q4 FY2021Dec 31, 2021-$4.32M–
Q3 FY2021Sep 30, 2021-$3.73M–
Q2 FY2021Jun 30, 2021-$4.27M–
Q1 FY2021Mar 31, 2021-$2.57M–
Q4 FY2020Dec 31, 2020-$2.44M–

More Allarity Therapeutics figures

See a number that looks wrong?